Search hospitals > Ontario > TORONTO
Mount Sinai Hospital
Claim this profileTORONTO, Ontario M5G 1X5
Global Leader in Bleeding
Global Leader in Crohn's Disease
Conducts research for Postpartum Hemorrhage
Conducts research for Breast Cancer
Conducts research for Inflammatory Bowel Disease
439 reported clinical trials
42 medical researchers
Summary
Mount Sinai Hospital is a medical facility located in TORONTO, Ontario. This center is recognized for care of Bleeding, Crohn's Disease, Postpartum Hemorrhage, Breast Cancer, Inflammatory Bowel Disease and other specialties. Mount Sinai Hospital is involved with conducting 439 clinical trials across 375 conditions. There are 42 research doctors associated with this hospital, such as Mrinalini Balki, MD, Jose Carvalho, MD, Yehoshua Gleicher, MD, MSc, and Christian Pagnoux, MD, MS, MPH.Top PIs
Mrinalini Balki, MDMount Sinai Hospital3 years of reported clinical research
Studies Postpartum Hemorrhage
Studies Bleeding
12 reported clinical trials
11 drugs studied
Jose Carvalho, MDMount Sinai Hospital5 years of reported clinical research
Studies Postpartum Hemorrhage
Studies Bleeding
7 reported clinical trials
11 drugs studied
Yehoshua Gleicher, MD, MScMount Sinai Hospital2 years of reported clinical research
Studies Total Knee Replacement
Studies Conduction Anesthesia
6 reported clinical trials
10 drugs studied
Christian Pagnoux, MD, MS, MPHMount Sinai Hospital9 years of reported clinical research
Studies Granulomatosis with Polyangiitis
Studies Systemic Vasculitis
5 reported clinical trials
6 drugs studied
Clinical Trials running at Mount Sinai Hospital
Crohn's Disease
Breast Cancer
Bleeding
Postpartum Hemorrhage
Necrotizing Enterocolitis
Neonatal Sepsis
Premature Birth
Bronchopulmonary Dysplasia
Cancer
Atrial Fibrillation
Guselkumab
for Crohn's Disease
This trial tests a medicine called guselkumab on adults with severe Crohn's disease who haven't responded to other treatments. The study will last over two years and will check both how well the medicine works and its safety. Guselkumab is already approved for treating other conditions like plaque psoriasis and psoriatic arthritis.
Recruiting1 award Phase 3
Combination Therapy
for Crohn's Disease
This trial is testing a new medication called JNJ-78934804 to see if it works better than two existing treatments for autoimmune conditions. The study will compare their effectiveness over several months.
Recruiting0 awards Phase 22 criteria
TAK-279
for Crohn's Disease
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. An endoscopy will be used to check the bowel for inflammation. The participants will be treated with TAK-279 for 52 weeks (1 year). During the study, participants will visit their study clinic 15 times.t
Recruiting0 awards Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Sinai Hospital?
Mount Sinai Hospital is a medical facility located in TORONTO, Ontario. This center is recognized for care of Bleeding, Crohn's Disease, Postpartum Hemorrhage, Breast Cancer, Inflammatory Bowel Disease and other specialties. Mount Sinai Hospital is involved with conducting 439 clinical trials across 375 conditions. There are 42 research doctors associated with this hospital, such as Mrinalini Balki, MD, Jose Carvalho, MD, Yehoshua Gleicher, MD, MSc, and Christian Pagnoux, MD, MS, MPH.
Where is Mount Sinai Hospital located?
Mount Sinai Hospital is located at 600 University Ave, Toronto, ON M5G 1X5. For subway access, take the Spadina-University line to Queen's Park Station or the College/Carlton streetcar to University Avenue. The hospital is situated south of College Street on the west side.
Who should I call to ask about financial aid or insurance network?
**Mount Sinai Medical Center Financial Assistance:**
- **Customer Service:** 305-674-2130
- **Availability:** Monday-Friday, 9:00am to 4:00pm
**The Mount Sinai Hospital Insurance and Billing Inquiries:**
- **Patient Financial Services:** 212-731-3100 or Toll-Free 866-682-9380
- **Availability:** Monday-Friday, 9:00am to 5:00pm
What insurance does Mount Sinai Hospital accept?
Mount Sinai Hospital accepts a wide range of insurance plans, including but not limited to Aetna HMO/PPO/POS/Medicare, Cigna HMO/PPO/EPO/POS, Empire BCBS PPO/POS/EPO/HMO, EmblemHealth, Fidelis, GHI, Healthfirst, HIP, Magnacare, Medicare, PHCS/Multiplan, Oscar, Oxford, POMCO, and United Healthcare. It's important to know that physician services provided in the hospital are billed separately from hospital charges. Patients should verify with their physician which insurance plans are accepted to ensure coverage.
What awards or recognition has Mount Sinai Hospital received?
Mount Sinai Hospital, located in Toronto, Ontario, is celebrated for its exceptional specialty programs, earning a spot in Newsweek's World's Best Specialized Hospitals 2023 for its groundbreaking diabetes research. It houses the Lunenfeld-Tanenbaum Research Institute, a leading biomedical research facility globally renowned for its comprehensive studies in women's and infants' health, cancer biology, stem cell biology, neurobiology, diabetes, arthritis, and more. This institution is dedicated to advancing health systems research, population health services, and systems biology.